Genetic variation in the NOS1AP gene is associated with the incidence of diabetes mellitus in users of calcium channel blockers

2008-11-01

Additional Metadata
Keywords	Calcium channel blocker, Diabetes mellitus type 2, Nitric oxide synthase, Pharmacogenetics
Persistent URL	doi.org/10.1007/s00125-008-1143-4, hdl.handle.net/1765/29099
Journal	Diabetologia: clinical and experimental diabetes and metabolism
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Becker, M.L, Visser, L.E, Newton-Cheh, C, Witteman, J.C.M, Hofman, A, Uitterlinden, A.G, & Stricker, B.H.Ch. (2008). Genetic variation in the NOS1AP gene is associated with the incidence of diabetes mellitus in users of calcium channel blockers. Diabetologia: clinical and experimental diabetes and metabolism, 51(11), 2138–2140. doi:10.1007/s00125-008-1143-4

Publication